Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 2
Submit an article Journal homepage
30
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

WINDECKER S, REMONDINO A, EBERLI FR et al.: Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N. Engl. J. Med. (2005) 353:653-662, and DIBRA A, KASTRATI A, MEHILLI J et al.: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N. Engl. J. Med. (2005) 353:663-670.

Sheila A Doggrell Senior Lecturer in Pharmacology, Division of Health Practice, Auckland University of Technology – Akoranga Campus, Northcote, Auckland, New Zealand. [email protected]
Pages 225-228 | Published online: 24 Jan 2006

Bibliography

  • SERRUYS PW, DE JAEGERE P, KIEMENEJI F et al.: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. (1994) 331:489-495.
  • DOGGRELL SA. Sirolimus- or paclitaxel-eluting stents to prevent coronary artery stenosis. Expert Opin. Pharmacother. (2004) 5: 2209-2220.
  • WINDECKER S, REMONDINO A, EBERLI FR et al.: Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N. Engl. J. Med. (2005) 353:653-662.
  • DIBRA A, KASTRATI A, MEHILLI J et al.: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N. Engl. J. Med. (2005) 353:663-670.
  • MOSES JW, LEON MB, POPMA JJ et al.: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. (2003) 349:1315-1325.
  • STONE GW, ELLIS SG, COX DA et al.: A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. (2004) 350:221-231.
  • KASTRATI A, MEHILLI J, VON BECARATH N et al.: Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA (2005) 293:165-171.
  • GOY J-J, STAUFFER J-C, SIEGENTHALER M, BENOIT A, SEYDOUX C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of intervention cardiology: the TAXi trial. J. Am Coll. Cardiol. (2005) 45:308-311.
  • ONG ATL, SERRUYS PW, AOKI J et al.: The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population. J. Am Coll. Cardiol. (2005) 45:1135-1141.
  • KASTRATI A, DIBRA A, EBERLE S et al.: Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA (2005) 294:819-825.

Website

  • www.clinicaltrialsresults.org Web-based repository for clinical study results. Accessed 6 January 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.